InsiderClue
Insiders · Profile

Yu Yong

Chief Scientific Officer at GENELUX. Filing since 18 Aug 2023. CIK 0001937482

Company
Date
Role
Action
Shares
Amount
Of holding
GNLX GENELUX Corp
31 Aug 2026
Chief Scientific Officer
Sold at will
9,683
$26.66K
3.6%
GNLX GENELUX Corp
4 Aug 2026
Chief Scientific Officer
Sold at will
653
$1.92K
0.2%
GNLX GENELUX Corp
11 May 2026
Chief Scientific Officer
Sold at will
605
$1.80K
0.4%
GNLX GENELUX Corp
24 Mar 2026
SVP, Clinical Development
Sold at will
906
$2.19K
0.6%
GNLX GENELUX Corp
17 Nov 2025
SVP, Clinical Development
Sold at will
973
$5.22K
0.7%
GNLX GENELUX Corp
21 Aug 2025
SVP, Clinical Development
Sold at will
3,219
$10.81K
2.1%
GNLX GENELUX Corp
12 May 2025
VP, Clinical Trial Operations
Sold at will
5,579
$16.29K
10.5%
GNLX GENELUX Corp
24 Jun 2024
VP, Clinical Trial Operations
Sold at will
6,849
$14.52K
38.7%
GNLX GENELUX Corp
29 May 2024
VP, Clinical Trial Operations
Bought
2,500
no price
opened
GNLX GENELUX Corp
15 Dec 2023
VP, Clinical Trial Operations
Sold at will
32,535
$428.18K
100%
GNLX GENELUX Corp
7 Dec 2023
VP, Clinical Trial Operations
Sold at will
36,800
$436.00K
53.1%
GNLX GENELUX Corp
21 Nov 2023
VP, Clinical Trial Operations
Sold at will
18,665
$191.56K
21.2%
GNLX GENELUX Corp
20 Nov 2023
VP, Clinical Trial Operations
Sold at will
14,594
$164.26K
14.2%
GNLX GENELUX Corp
17 Nov 2023
VP, Clinical Trial Operations
Sold at will
3,541
$46.17K
3.3%
GNLX GENELUX Corp
24 Oct 2023
VP, Clinical Trial Operations
Sold at will
5,200
$99.35K
4.7%
GNLX GENELUX Corp
10 Oct 2023
VP, Clinical Trial Operations
Sold at will
5,200
$114.46K
4.7%
GNLX GENELUX Corp
26 Sep 2023
VP, Clinical Trial Operations
Sold at will
5,200
$122.53K
4.7%
GNLX GENELUX Corp
20 Sep 2023
VP, Clinical Trial Operations
Sold at will
6,000
$167.79K
5.4%
GNLX GENELUX Corp
15 Sep 2023
VP, Clinical Trial Operations
Sold at will
10,400
$227.63K
8.9%
GNLX GENELUX Corp
13 Sep 2023
VP, Clinical Trial Operations
Sold at will
29,800
$629.93K
21.9%
GNLX GENELUX Corp
30 Aug 2023
VP, Clinical Trial Operations
Sold at will
19,800
$489.06K
12.7%
GNLX GENELUX Corp
18 Aug 2023
VP, Clinical Trial Operations
Sold at will
3,265
$77.48K
2.1%
22 decisions on file.